Citation: J. Dow, BANKS, MARKETS, AND THE ALLOCATION OF RISKS IN AN ECONOMY - COMMENT, JITE. Journal of institutional and theoretical economics, 154(1), 1998, pp. 346-351
Citation: T. Green et al., FORMIC-ACID EXCRETION IN RATS EXPOSED TO TRICHLOROETHYLENE - A POSSIBLE EXPLANATION FOR RENAL TOXICITY IN LONG-TERM STUDIES, Toxicology, 127(1-3), 1998, pp. 39-47
Authors:
SCHWARZ ER
POLLICK C
DOW J
PATTERSON M
BIRNBAUM Y
KLONER RA
Citation: Er. Schwarz et al., A SMALL ANIMAL-MODEL OF NONISCHEMIC CARDIOMYOPATHY AND ITS EVALUATIONBY TRANSTHORACIC ECHOCARDIOGRAPHY, Cardiovascular Research, 39(1), 1998, pp. 216-223
Citation: P. Sanwaldducray et J. Dow, PREDICTION OF THE PHARMACOKINETIC PARAMETERS OF REDUCED-DOLASETRON INMAN USING IN-VITRO IN-VIVO AND INTERSPECIES ALLOMETRIC SCALING, Xenobiotica, 27(2), 1997, pp. 189-201
Citation: J. Dow et G. Gorton, NOISE TRADING, DELEGATED PORTFOLIO MANAGEMENT, AND ECONOMIC WELFARE, Journal of political economy, 105(5), 1997, pp. 1024-1050
Citation: J. Dow et G. Gorton, STOCK-MARKET EFFICIENCY AND ECONOMIC-EFFICIENCY - IS THERE A CONNECTION, The Journal of finance, 52(3), 1997, pp. 1087-1129
Citation: T. Green et al., THE ROLE OF GLUTATHIONE CONJUGATION IN THE DEVELOPMENT OF KIDNEY TUMORS IN RATS EXPOSED TO TRICHLOROETHYLENE, Chemico-biological interactions, 105(2), 1997, pp. 99-117
Citation: P. Sanwald et al., USE OF ELECTROSPRAY-IONIZATION LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY TO STUDY THE ROLE OF CYP2D6 IN THE IN-VITRO METABOLISM OF 5-HYDROXYTRYPTAMINE RECEPTOR ANTAGONISTS, Journal of chromatography B. Biomedical applications, 678(1), 1996, pp. 53-61
Citation: P. Sanwald et al., CHARACTERIZATION OF THE CYTOCHROME-P450 ENZYMES INVOLVED IN THE IN-VITRO METABOLISM OF DOLASETRON - COMPARISON WITH OTHER INDOLE-CONTAINING5-HT3 ANTAGONISTS, Drug metabolism and disposition, 24(5), 1996, pp. 602-609
Citation: J. Dow et al., COMPARISON OF THE PHARMACOKINETICS OF DOLASETRON AND ITS MAJOR ACTIVEMETABOLITE, REDUCED DOLASETRON, IN DOG, Journal of pharmaceutical sciences, 85(7), 1996, pp. 685-689
Authors:
SANWALD P
BLANKSON EA
DULERY BD
SCHOUN J
HUEBERT ND
DOW J
Citation: P. Sanwald et al., ISOCRATIC HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE SEPARATION OF TESTOSTERONE METABOLITES, Journal of chromatography B. Biomedical applications, 672(2), 1995, pp. 207-215
Citation: J. Dow et G. Gorton, PROFITABLE INFORMED TRADING IN A SIMPLE GENERAL EQUILIBRIUM-MODEL OF ASSET PRICING, Journal of economic theory, 67(2), 1995, pp. 327-369
Citation: Hl. Cole et al., DEFAULT, SETTLEMENT, AND SIGNALING - LENDING RESUMPTION IN A REPUTATIONAL MODEL OF SOVEREIGN DEBT, International economic review, 36(2), 1995, pp. 365-385
Authors:
DOW J
DULERY BD
HORNSPERGER JM
DIFRANCESCO GF
KESHARY P
HAEGELE KD
Citation: J. Dow et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ACETYLCHOLINESTERASE INHIBITOR 2,2,2-TRIFLUORO-1-(3-TRIMETHYLSILYLPHENYL) ETHANONE IN DOG - POTENTIAL FOR TRANSDERMAL PATCH DELIVERY, Arzneimittel-Forschung, 45-2(12), 1995, pp. 1245-1252
Authors:
HORNSPERGER JM
COLLARD JN
HEYDT JG
GIACOBINI E
FUNES S
DOW J
SCHIRLIN D
Citation: Jm. Hornsperger et al., TRIMETHYLSILYLATED TRIFLUOROMETHYL KETONES, A NOVEL CLASS OF ACETYLCHOLINESTERASE INHIBITORS - BIOCHEMICAL AND PHARMACOLOGICAL PROFILE OF MDL-73,745, Biochemical Society transactions, 22(3), 1994, pp. 758-763
Authors:
DOW J
PIRIOU F
WOLF E
DULERY BD
HAEGELE KD
Citation: J. Dow et al., NOVEL CARBAMATE METABOLITES OF MOFEGILINE, A PRIMARY AMINE MONOAMINE-OXIDASE-B INHIBITOR, IN DOGS AND HUMANS, Drug metabolism and disposition, 22(5), 1994, pp. 738-749
Citation: J. Dow et Srd. Werlang, NASH EQUILIBRIUM UNDER KNIGHTIAN UNCERTAINTY - BREAKING DOWN BACKWARDINDUCTION, Journal of economic theory, 64(2), 1994, pp. 305-324
Authors:
PETTY MA
LUKOVIC L
GRISAR JM
DOW J
BOLKENIUS FN
DEJONG W
Citation: Ma. Petty et al., MYOCARDIAL PROTECTION BY A CARDIOSELECTIVE FREE-RADICAL SCAVENGER, European journal of pharmacology, 255(1-3), 1994, pp. 215-222